Number of Patients | Dihydroergocryptine | Pramipexole |
Randomized | 56 | 60 |
Not included (consent withdrawal) | - | - |
Safety population | 56 | 60 |
Completed | 39 | 46 |
Discontinued | 17 | 14 |
PP population | 39 | 46 |
Main cause of discontinuation | ||
Adverse event (nausea) | 2 | - |
Abandon (lost to follow up) | 1 | 2 |
Excluded | 12 | 8 |
Eliminated | 2 | 4 |